BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BCRX is expected to report earnings to fall 44.46% to -7 cents per share on May 01

BioCryst Pharmaceuticals BCRX Stock Earnings Reports

Q1'25

Est.

$-0.07

Q4'24

Missed

by $0.06

Q3'24

Est.

$-0.07

Q2'24

Beat

by $0.11

Q1'24

Beat

by $0.04

The last earnings report on February 24 showed earnings per share of -12 cents, missing the estimate of -7 cents. With 3.58M shares outstanding, the current market capitalization sits at 1.63B.

View a ticker or compare two or three

Compare

BCRX